Compare Alibaba Group (BABA) vs Herbalife Nutrition Ltd (HLF) Price & Performance

Alibaba (BABA) trades at $124.80, down 5.69% on the day amid ongoing legal pressures and earnings misses. The stock shows bullish technical signals with strong moving average support but faces fundamental headwinds from three consecutive quarterly EPS misses. Revenue growth remains positive at $996.35 billion for 2025, with improved net income margin of 13.05%, though cash flow turned negative at -$97.16 billion due to heavy investing activity.

Despite analyst optimism with 86% buy ratings and $195 consensus target, significant legal risks from multiple class action lawsuits and recent earnings underperformance create near-term uncertainty. The 56% upside to target suggests potential value if legal and operational challenges resolve, but investors face elevated regulatory and execution risks in the Chinese market environment.

Herbalife (HLF) trades at $11.695, up 1.52% on the day, with a bearish technical outlook per moving averages. The company reported Q2 2026 net sales of $1.3 billion, a 5.4% year-over-year increase, though EPS of $0.51 missed estimates. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24. Positive news includes being named to TIME's America's Best Companies 2026 list, but a planned CFO transition in December 2026 introduces uncertainty.

The outlook is mixed; strong sales growth and low valuation metrics offer potential upside, but recent earnings misses, a high debt load, and negative shareholder equity pose significant risks. Analyst consensus leans bullish with 53.84% buy ratings, yet the stock faces headwinds from competitive pressures and margin volatility.